See the DrugPatentWatch profile for Etomidate
What side effects can etomidate cause?
Etomidate (often used for rapid sequence intubation to induce anesthesia) can cause a range of effects, some related to its action on blood pressure, breathing, and the heart, as well as common anesthesia-related reactions. Reported adverse effects include:
- Low blood pressure (hypotension), sometimes requiring treatment
- Slowed breathing or breathing problems, especially if ventilation isn’t supported
- Nausea and vomiting after the procedure
- Injection-site pain or irritation
- Head movement or muscle jerks (myoclonus) during induction
- A slower heart rate (bradycardia) or other rhythm changes in some patients
- Dizziness or sedation-related effects after the procedure
What are the most serious etomidate side effects patients should watch for?
The most concerning complications are those that can quickly affect oxygenation and circulation:
- Severe hypotension (significant drops in blood pressure)
- Breathing suppression (leading to low oxygen levels), particularly if airway support is delayed
- Allergic reactions (such as rash, swelling, or trouble breathing), though this is uncommon
If etomidate is being used in an emergency or procedure setting, clinicians monitor closely because these effects can be managed in real time.
Why does etomidate affect blood pressure and breathing?
Etomidate can reduce cardiovascular tone, which is why hypotension is a known risk. It can also depress respiration and affect the airway reflexes that protect breathing, which is why it’s used with close monitoring and often with assisted ventilation depending on the patient and setting.
Are there risks related to adrenal hormones with etomidate?
Etomidate is known for a potential endocrine effect: it can suppress adrenal steroid production (commonly described as adrenal suppression) in some patients. This matters most in critically ill patients, where stress hormone needs are higher. Clinicians weigh the risk when choosing induction agents and may monitor or use alternative strategies depending on the clinical situation.
How common are etomidate side effects?
How often side effects occur depends on dose, patient condition, and whether the setting is emergency intubation, procedural sedation, or surgery. For example, hypotension and respiratory effects are more relevant in unstable or critically ill patients, while myoclonus (jerking movements) may appear during induction.
What should patients tell a clinician before receiving etomidate?
Patients can help clinicians reduce risk by sharing:
- History of adrenal disease or endocrine disorders
- Prior reactions to anesthesia or similar medicines
- Significant heart or blood-pressure problems
- Respiratory disease (for example, severe COPD, sleep apnea) or recent breathing issues
If the patient can’t communicate (common in emergency intubation), the medical team relies on records, medication history, and observed vitals.
Can etomidate be used safely in people who are critically ill?
Clinicians do use etomidate in critical care and emergency settings, but the adrenal suppression concern can be more important there. Choice of induction agent, dosing, and monitoring are tailored to the patient’s stability and goals of care.
Does etomidate have different side effects than other induction drugs?
Compared with some alternatives, etomidate is often chosen for its hemodynamic profile in specific cases, but it comes with tradeoffs such as adrenal suppression risk. Different induction agents can shift the balance of respiratory effects, blood pressure effects, and other anesthesia reactions.
Sources
No external sources were provided in your request. If you want, tell me where you’re getting your information from (hospital protocol, medication label, or a country), and I can tailor the side-effect profile to the exact etomidate product and dosing context.